Hologic, Inc. (HOLX)
Automate Your Wheel Strategy on HOLX
With Tiblio's Option Bot, you can configure your own wheel strategy including HOLX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HOLX
- Rev/Share 18.005
- Book/Share 21.5879
- PB 3.1263
- Debt/Equity 0.5209
- CurrentRatio 3.5547
- ROIC 0.0743
- MktCap 15011077342.0
- FreeCF/Share 4.3608
- PFCF 15.3456
- PE 27.1747
- Debt/Assets 0.2864
- DivYield 0
- ROE 0.1151
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 2
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | HOLX | Argus | Hold | Buy | -- | $80 | Aug. 18, 2025 |
| Upgrade | HOLX | RBC Capital Mkts | Sector Perform | Outperform | -- | $87 | Aug. 6, 2025 |
| Upgrade | HOLX | Citigroup | Neutral | Buy | -- | $80 | July 9, 2025 |
| Reiterated | HOLX | Needham | -- | Hold | -- | -- | May 27, 2025 |
| Downgrade | HOLX | Argus | Buy | Hold | -- | -- | March 3, 2025 |
| Downgrade | HOLX | Leerink Partners | Outperform | Market Perform | $80 | $75 | Feb. 6, 2025 |
| Downgrade | HOLX | Needham | Buy | Hold | -- | -- | Feb. 3, 2025 |
| Initiation | HOLX | Wolfe Research | -- | Peer Perform | -- | -- | Dec. 13, 2024 |
| Reiterated | HOLX | Needham | -- | Buy | -- | $90 | Dec. 10, 2024 |
| Initiation | HOLX | Jefferies | -- | Hold | -- | $85 | Dec. 10, 2024 |
News
New Product Launches to Support HOLX Stock Amid Macro Issues
Published: March 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic's Surgical business has been driving strong broad-based performance by expanding access to technologies in new global markets.
Read More
HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip?
Published: March 19, 2025 by: Zacks Investment Research
Sentiment: Positive
As Hologic works through the changing macroeconomic and geopolitical landscape, its long-term potential makes it a solid hold.
Read More
Why Is Hologic (HOLX) Down 4.5% Since Last Earnings Report?
Published: March 07, 2025 by: Zacks Investment Research
Sentiment: Negative
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock?
Read More
Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software
Published: February 20, 2025 by: Business Wire
Sentiment: Neutral
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #cemark--Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software.
Read More
Two S&P 500 hidden gems to buy right now
Published: February 18, 2025 by: Finbold
Sentiment: Positive
Although the benchmark S&P 500's biggest names tend to dominate investor attention, the index also features lesser-known stocks with significant growth potential.
Read More
HOLX's New Offerings Likely to Revive Stock Amid Macro Woes
Published: February 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic's Surgical business has been recording strong broad-based performance by expanding access to technologies into new global markets.
Read More
Here's Why You Should Retain HOLX Stock in Your Portfolio Now
Published: February 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic's strength in the molecular diagnostics wing instills optimism among investors. Yet, a dull macroeconomic environment raises concerns.
Read More
About Hologic, Inc. (HOLX)
- IPO Date 1990-03-01
- Website https://www.hologic.com
- Industry Medical - Instruments & Supplies
- CEO Stephen P. MacMillan
- Employees 7063